These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4593269)

  • 21. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical effects of rifampicin applied every other day for severe cavitary pulmonary tuberculosis].
    Hashimoto T; Takahashi S; Kasai K; Tamura M; Yamada M
    Kekkaku; 1972 Aug; 47(8):273-7. PubMed ID: 4660855
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 26. [A controlled comparison of daily and intermittent administration of rifampicin in retreatment of pulmonary tuberculosis].
    Yamamoto K; Aizawa H; Sasaoka M; Kawamori Y; Kakuno J
    Kekkaku; 1972 Dec; 47(12):467-73. PubMed ID: 4652425
    [No Abstract]   [Full Text] [Related]  

  • 27. [Behavior of blood levels of rifampicin during the course of treatment].
    Nitti V; Delli Veneri F; Ninni A; Meola G
    Arch Monaldi; 1970; 25(4):310-20. PubMed ID: 4949912
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of age and sex on the incidence of the 'flu' syndrome and rifampicin-dependent antibodies in patients on intermittent rifampicin for tuberculosis.
    Tubercle; 1975 Sep; 56(3):173-8. PubMed ID: 766339
    [No Abstract]   [Full Text] [Related]  

  • 29. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Prim Care; 1980 Sep; 7(3):513-27. PubMed ID: 7003628
    [No Abstract]   [Full Text] [Related]  

  • 31. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis.
    Gyselen A
    Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship between rifampicin-dependent antibody scores, serum rifampicin concentrations and symptoms in patients with adverse reactions to intermittent rifampicin treatment.
    O'Mahony MG; Kar CW
    Clin Allergy; 1973 Dec; 3(4):353-62. PubMed ID: 4784489
    [No Abstract]   [Full Text] [Related]  

  • 35. Trial of rifampicin in the treatment of pulmonary tuberculosis. A preliminary report.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1971 May; 54(5):304-11. PubMed ID: 5580059
    [No Abstract]   [Full Text] [Related]  

  • 36. Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1972 Apr; 55(4):235-7. PubMed ID: 5022496
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of rifampicin on the synthesis of antibodies to fraction I of vaccine EV].
    Nikitin AV; Smolkina TV; Zebrev AI; Fishman VM; Prokof'ev MM; Astashkina VL
    Antibiot Khimioter; 1992 Oct; 37(10):27-9. PubMed ID: 1296529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical trial with rifampicin i.v. 300 and 600 in tuberculosis patients].
    Jungbluth H
    Prax Klin Pneumol; 1984 May; 38(5):177-81. PubMed ID: 6379634
    [No Abstract]   [Full Text] [Related]  

  • 40. [56 recent pulmonary tuberculosis cases treated with combined rifampicin-isoniazid in a controlled experiment].
    Constans P; Morin Y; Saint-Paul M; Bonnaud G; Coury C; Bariéty M
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):145-62. PubMed ID: 4916251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.